{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:17:07Z","timestamp":1791685027708,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The application of combination therapy for cancer treatment is limited due to poor tumor-specific drug delivery and the abscopal effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Here, PD-L1- and CD44-responsive multifunctional nanoparticles were developed using a polymer complex of polyethyleneimine and oleic acid (PEI-OA) and loaded with two chemotherapeutic drugs (paclitaxel and chloroquine), an antigen (ovalbumin), an immunopotentiator (CpG), and an immune checkpoint inhibitor (anti-PD-L1 antibody).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PEI-OA greatly improved the drug loading capacity and encapsulation efficiency of the nanoplatform, while the anti-PD-L1 antibody significantly increased its cellular uptake compared to other treatment formulations. Pharmacodynamic experiments confirmed that the anti-PD-L1 antibody can strongly inhibit primary breast cancer and increase levels of CD4+ and CD8+ T cell at the tumor site. In addition, chloroquine reversed the \u201cimmune-cold\u201d environment and improved the anti-tumor effect of both chemotherapeutics and immune checkpoint inhibitors, while it induced strong immune memory and prevented lung metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our strategy serves as a promising approach to the rational design of nanodelivery systems for simultaneous active targeting, autophagy inhibition, and chemotherapy that can be combined with immune-checkpoint inhibitors for enhanced breast cancer treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02614-8","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:02:34Z","timestamp":1666915354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Yibin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-6338","authenticated-orcid":false,"given":"Jingwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"2614_CR1","doi-asserted-by":"publisher","first-page":"1800025","DOI":"10.1002\/adfm.201800025","volume":"28","author":"J Kuang","year":"2018","unstructured":"Kuang J, Song W, Yin J, Zeng X, Han S, Zhao YP, et al. iRGD modified chemo-immunotherapeutic nanoparticles for enhanced immunotherapy against glioblastoma. Adv Func Mater. 2018;28:1800025.","journal-title":"Adv Func Mater."},{"key":"2614_CR2","doi-asserted-by":"publisher","first-page":"2003757","DOI":"10.1002\/adfm.202003757","volume":"30","author":"H Du","year":"2020","unstructured":"Du H, Zhao S, Wang Y, Wang Z, Chen B, Yan Y, et al. pH\/Cathepsin B hierarchical-responsive nanoconjugates for enhanced tumor penetration and chemo-immunotherapy. Adv Funct Mater. 2020;30:2003757.","journal-title":"Adv Funct Mater."},{"key":"2614_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41467-020-20588-0","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Liang Y, Yin Y, Zhang J, Su W, White AM, et al. Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance. Nat Commun. 2021;12:312.","journal-title":"Nat Commun."},{"key":"2614_CR4","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1038\/s41467-019-11730-8","volume":"10","author":"C Song","year":"2019","unstructured":"Song C, Phuengkham H, Kim YS, Dinh VV, Lee I, Shin IW, et al. Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Nat Commun. 2019;10:3745.","journal-title":"Nat Commun."},{"key":"2614_CR5","doi-asserted-by":"publisher","first-page":"1801868","DOI":"10.1002\/advs.201801868","volume":"6","author":"C Deng","year":"2019","unstructured":"Deng C, Zhang Q, Jia M, Zhao J, Sun X, Gong T, et al. Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast cancer. Adv Sci. 2019;6:1801868.","journal-title":"Adv Sci."},{"key":"2614_CR6","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-021-23923-1","volume":"12","author":"F Hu","year":"2021","unstructured":"Hu F, Song D, Yan Y, Huang C, Shen C, Lan J, et al. IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat Commun. 2021;12:3651.","journal-title":"Nat Commun."},{"key":"2614_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41388-018-0423-9","volume":"38","author":"J Feng","year":"2019","unstructured":"Feng J, Zhang Y, She X, Sun Y, Fan L, Ren X, et al. Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1\u03b1 stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment. Oncogene. 2019;38:103\u201319.","journal-title":"Oncogene."},{"key":"2614_CR8","doi-asserted-by":"publisher","first-page":"eabi6442","DOI":"10.1126\/sciadv.abi6442","volume":"7","author":"S Haq","year":"2021","unstructured":"Haq S, Wang H, Grondin J, Banskota S, Marshall JK, Khan II, et al. Disruption of autophagy by increased 5-HT alters gut microbiota and enhances susceptibility to experimental colitis and Crohn\u2019s disease. Sci Adv. 2021;7:eabi6442.","journal-title":"Sci Adv."},{"key":"2614_CR9","doi-asserted-by":"publisher","first-page":"eabb9561","DOI":"10.1126\/sciimmunol.abb9561","volume":"5","author":"TM Young","year":"2020","unstructured":"Young TM, Reyes C, Pasnikowski E, Castanaro C, Wong C, Decker CE, et al. Autophagy protects tumors from T cell\u2013mediated cytotoxicity via inhibition of TNF\u03b1-induced apoptosis. Sci Immunol. 2020;5:eabb9561.","journal-title":"Sci Immunol."},{"key":"2614_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s43018-021-00237-1","volume":"2","author":"Y Qiao","year":"2021","unstructured":"Qiao Y, Choi JE, Tien JC, Simko SA, Rajendiran T, Vo JN, et al. Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer. Nat Cancer. 2021;2:978\u201393.","journal-title":"Nat Cancer."},{"key":"2614_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","volume":"21","author":"H Xia","year":"2021","unstructured":"Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Nat Rev Cancer. 2021;21:281\u201397.","journal-title":"Nat Rev Cancer."},{"key":"2614_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41388-021-02115-7","volume":"41","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhao H, Liang W, Jiang E, Zhou X, Shao Z, et al. Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3\/SOX2 axis. Oncogene. 2022;41:634\u201346.","journal-title":"Oncogene."},{"key":"2614_CR13","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/s41467-020-17395-y","volume":"11","author":"ZL Li","year":"2020","unstructured":"Li ZL, Zhang HL, Huang Y, Huang JH, Sun P, Zhou NN, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806.","journal-title":"Nat Commun."},{"key":"2614_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s43018-020-00110-7","volume":"1","author":"PL Poillet","year":"2020","unstructured":"Poillet PL, Sharp DW, Yang Y, Laddha SV, Ibrahim M, Bommareddy PK, et al. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response. Nat Cancer. 2020;1:923\u201334.","journal-title":"Nat Cancer."},{"key":"2614_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ni.3025","volume":"15","author":"X Xu","year":"2014","unstructured":"Xu X, Araki K, Li S, Han JH, Ye L, Tan WG, et al. Autophagy is essential for effector CD8+ T cell survival and memory formation. Nat Immunol. 2014;15:1152\u201361.","journal-title":"Nat Immunol."},{"key":"2614_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019;9:1167\u201381.","journal-title":"Cancer Discov."},{"key":"2614_CR17","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41467-021-21829-6","volume":"12","author":"LA Ligeon","year":"2021","unstructured":"Ligeon LA, Pena FM, Vanoaica LD, N\u00fa\u00f1ez NG, Talwar D, Dick TP, et al. Oxidation inhibits autophagy protein deconjugation from phagosomes to sustain MHC class II restricted antigen presentation. Nat Commun. 2021;12:1508.","journal-title":"Nat Commun."},{"key":"2614_CR18","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1038\/s41467-018-06529-y","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Sha R, Zhang L, Zhang W, Jin P, Xu W, et al. Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer. Nat Commun. 2018;9:4236.","journal-title":"Nat Commun."},{"key":"2614_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4161\/auto.8.2.18554","volume":"8","author":"P Maycotte","year":"2012","unstructured":"Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, Thorburn A. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 2012;8:200\u201312.","journal-title":"Autophagy."},{"key":"2614_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4161\/auto.27901","volume":"10","author":"P Paola","year":"2014","unstructured":"Paola P, Angela S, Chiara Z, et al. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine. Autophagy. 2014;10:562\u201371.","journal-title":"Autophagy."},{"key":"2614_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto K, Venida A, Yano J, Biancur DE, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100\u20135.","journal-title":"Nature."},{"key":"2614_CR22","doi-asserted-by":"publisher","first-page":"117964","DOI":"10.1016\/j.carbpol.2021.117964","volume":"263","author":"J Luo","year":"2021","unstructured":"Luo J, Zhang Z, Zeng Y, Dong Y, Ma L. Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis. Carbohydr Polym. 2021;263:117964.","journal-title":"Carbohydr Polym."},{"key":"2614_CR23","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1038\/s41596-020-0393-6","volume":"15","author":"MA Dobrovolskaia","year":"2020","unstructured":"Dobrovolskaia MA, Afonin KA. Use of human peripheral blood mononuclear cells to define immunological properties of nucleic acid nanoparticles. Nat Protoc. 2020;15:3678\u201398.","journal-title":"Nat Protoc."},{"key":"2614_CR24","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/hep.31418","volume":"73","author":"J Zhang","year":"2021","unstructured":"Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, et al. Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells. Hepatology. 2021;73:1140\u201357.","journal-title":"Hepatology."},{"key":"2614_CR25","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1021\/acsnano.8b06924","volume":"13","author":"J Luo","year":"2019","unstructured":"Luo J, Zhang P, Zhao T, Jia M, Yin P, Li W, et al. Golgi apparatus-targeted chondroitin-modified nanomicelles suppress hepatic stellate cell activation for the management of liver fibrosis. ACS Nano. 2019;13:3910\u201323.","journal-title":"ACS Nano."},{"key":"2614_CR26","doi-asserted-by":"publisher","first-page":"120988","DOI":"10.1016\/j.biomaterials.2021.120988","volume":"275","author":"C Chen","year":"2021","unstructured":"Chen C, Guo Q, Fu H, Yu J, Wang L, Sun Y, et al. Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis. Biomaterials. 2021;275:120988.","journal-title":"Biomaterials."},{"key":"2614_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4161\/auto.5.8.9842","volume":"5","author":"Q Zhang","year":"2009","unstructured":"Zhang Q, Yang W, Man N, Zheng F, Shen Y, Sun K, et al. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal. Autophagy. 2009;5:1107\u201317.","journal-title":"Autophagy."},{"key":"2614_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/molbev\/msaa195","volume":"38","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Lai F, Wang X, Shang D, Zou J, Luo M, et al. Srag regulates autophagy via integrating into a preexisting autophagy pathway in testis. Mol Biol Evol. 2021;38:128\u201341.","journal-title":"Mol Biol Evol."},{"key":"2614_CR29","doi-asserted-by":"publisher","first-page":"117459","DOI":"10.1016\/j.carbpol.2020.117459","volume":"254","author":"X Shi","year":"2021","unstructured":"Shi X, Yang X, Liu M, Wang R, Qiu N, Liu Y, et al. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer. Carbohydr Polym. 2021;254:117459.","journal-title":"Carbohydr Polym."},{"key":"2614_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","volume":"600","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Kawazoe A, Ya\u00f1ez P, Li N, Lonardi S, Kolesnik O, et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature. 2021;600:727\u201330.","journal-title":"Nature."},{"key":"2614_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","volume":"103","author":"CD Dumitru","year":"2000","unstructured":"Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, et al. TNF-\u03b1 induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway. Cell. 2000;103:1071\u201383.","journal-title":"Cell."},{"key":"2614_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Vermi W, Lee J, Lonardi S, Gilfillan S, Newberry R, et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells. Immunity. 2013;38:769\u201381.","journal-title":"Immunity."},{"key":"2614_CR33","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1009","volume":"4","author":"SM Kaech","year":"2003","unstructured":"Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4:1191\u20138.","journal-title":"Nat Immunol."},{"key":"2614_CR34","doi-asserted-by":"publisher","first-page":"2106932","DOI":"10.1002\/adfm.202106932","volume":"32","author":"L Uson","year":"2021","unstructured":"Uson L, Yus C, Mendoza G, Leroy E, Irusta S, Alejo T, et al. Nanoengineering palladium plasmonic nanosheets inside polymer nanospheres for photothermal therapy and targeted drug delivery. Adv Funct Mater. 2021;32:2106932.","journal-title":"Adv Funct Mater."},{"key":"2614_CR35","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1038\/s41467-021-27078-x","volume":"12","author":"H Fang","year":"2021","unstructured":"Fang H, Guo Z, Chen J, Lin L, Hu Y, Li Y, et al. Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo. Nat Commun. 2021;12:6742.","journal-title":"Nat Commun."},{"key":"2614_CR36","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","volume":"2","author":"C Bosc","year":"2021","unstructured":"Bosc C, Saland E, Bousard A, Gadaud N, Sabatier M, Cognet G, et al. Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia. Nat Cancer. 2021;2:1204\u201323.","journal-title":"Nat Cancer."},{"key":"2614_CR37","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1021\/acsnano.1c00476","volume":"15","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Zhang J, Song J, Liu Y, Ren X, Zhao Y. Protein-based nanomedicine for therapeutic benefits of cancer. ACS Nano. 2021;15:8001\u201338.","journal-title":"ACS Nano."},{"key":"2614_CR38","doi-asserted-by":"publisher","first-page":"119925","DOI":"10.1016\/j.biomaterials.2020.119925","volume":"242","author":"M Lu","year":"2020","unstructured":"Lu M, Huang Y. Bioinspired exosome-like therapeutics and delivery nanoplatforms. Biomaterials. 2020;242:119925.","journal-title":"Biomaterials."},{"key":"2614_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41578-021-00362-4","volume":"7","author":"PP Kalelkar","year":"2021","unstructured":"Kalelkar PP, Riddick M, Garc\u00eda AJ. Biomaterial-based antimicrobial therapies for the treatment of bacterial infections. Nat Rev Mater. 2021;7:39\u201354.","journal-title":"Nat Rev Mater."},{"key":"2614_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41467-020-20375-x","volume":"12","author":"R Balu","year":"2021","unstructured":"Balu R, Dutta NK, Dutta AK, Choudhury NR. Resilin-mimetics as a smart biomaterial platform for biomedical applications. Nat Commun. 2021;12:149.","journal-title":"Nat Commun."},{"key":"2614_CR41","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","volume":"17","author":"H Wang","year":"2018","unstructured":"Wang H, Mooney DJ. Biomaterial-assisted targeted modulation of immune cells in cancer treatment. Nat Mater. 2018;17:761\u201372.","journal-title":"Nat Mater."},{"key":"2614_CR42","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1038\/s41467-020-19540-z","volume":"11","author":"H Wang","year":"2020","unstructured":"Wang H, Najibi AJ, Sobral MC, Seo BR, Lee JY, Wu D, et al. Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors. Nat Commun. 2020;11:5696.","journal-title":"Nat Commun."},{"key":"2614_CR43","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1038\/504S16a","volume":"504","author":"E Dolgin","year":"2013","unstructured":"Dolgin E. Cancer vaccines: Material breach. Nature. 2013;504:S16\u20137.","journal-title":"Nature."},{"key":"2614_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","volume":"7","author":"GA Roth","year":"2021","unstructured":"Roth GA, Picece VCTM, Ou BS, Luo W, Pulendran B, Appel EA. Designing spatial and temporal control of vaccine responses. Nat Rev Mater. 2021;7:174\u201395.","journal-title":"Nat Rev Mater."},{"key":"2614_CR45","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1002\/adfm.200801844","volume":"19","author":"FM Kievit","year":"2009","unstructured":"Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee D, et al. PEI\u2013PEG\u2013chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv Funct Mater. 2009;19:2244\u201351.","journal-title":"Adv Funct Mater."},{"key":"2614_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2217\/imt.12.162","volume":"5","author":"MIG Raaijmakers","year":"2013","unstructured":"Raaijmakers MIG, Rozati S, Goldinger SM, Widmer DS, Dummer R, Levesque MP. Melanoma immunotherapy: historical precedents, recent successes and future prospects. Immunotherapy. 2013;5:169\u201382.","journal-title":"Immunotherapy."},{"key":"2614_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.phrs.2017.07.006","volume":"123","author":"B Pulluri","year":"2017","unstructured":"Pulluri B, Kumar A, Shaheen M, Jeter J, Sundararajan S. Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance. Pharmacol Res. 2017;123:95\u2013102.","journal-title":"Pharmacol Res."},{"key":"2614_CR48","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.4161\/onci.21335","volume":"1","author":"L Zitvogel","year":"2012","unstructured":"Zitvogel L, Kroemer G. Targeting PD-1\/PD-L1 interactions for cancer immunotherapy. Oncoimmunology. 2012;1:1223\u20135.","journal-title":"Oncoimmunology."},{"key":"2614_CR49","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1111\/1759-7714.13588","volume":"11","author":"N Kataoka","year":"2020","unstructured":"Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Sato I, Tani N, et al. Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer. Thorac Cancer. 2020;11:2740\u20132.","journal-title":"Thorac Cancer."},{"issue":"1","key":"2614_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-019-00489-1","volume":"43","author":"D Cruceriu","year":"2020","unstructured":"Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-alpha) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol. 2020;43(1):1\u201318.","journal-title":"Cell Oncol."},{"issue":"3","key":"2614_CR51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.17219\/acem\/62120","volume":"26","author":"Y Ma","year":"2017","unstructured":"Ma Y, Ren Y, Dai ZJ, Wu CJ, Ji YH, Xu J. IL-6, IL-8 and TNF-\u03b1 levels correlate with disease stage in breast cancer patients. Adv Clin Exp Med. 2017;26(3):421\u20136.","journal-title":"Adv Clin Exp Med."},{"issue":"4","key":"2614_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ijc.31357","volume":"143","author":"Y Gao","year":"2018","unstructured":"Gao Y, Yang J, Cai Y, Fu S, Zhang N, Fu X, et al. IFN-gamma-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling. Int J Cancer. 2018;143(4):931\u201343.","journal-title":"Int J Cancer."},{"key":"2614_CR53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jconrel.2021.08.020","volume":"338","author":"Q Li","year":"2021","unstructured":"Li Q, Zhou Y, He W, Ren X, Zhang M, Jiang Y, et al. Platelet-armored nanoplatform to harmonize janus-faced IFN-gamma against tumor recurrence and metastasis. J Control Release. 2021;338:33\u201345.","journal-title":"J Control Release."},{"issue":"3","key":"2614_CR54","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/anie.201804882","volume":"58","author":"X Duan","year":"2019","unstructured":"Duan X, Chan C, Lin W. Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy. Angew Chem Int Ed Engl. 2019;58(3):670\u201380.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"2614_CR55","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova J, Kepp O. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013.","journal-title":"Cell Death Dis."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02614-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02614-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02614-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T08:04:30Z","timestamp":1667117070000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02614-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2614"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02614-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee of Wuhan Institute of Virology (Approval number: WIVA04202102).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}